In Vivo Production of Mesenchymal Stromal Cells After Injection of Autologous Platelet-Rich Plasma Activated by Recombinant Human Soluble Tissue Factor in the Bone Marrow of Healthy Volunteers
Authors:
- 1 January 2014
- journal article
- clinical trial
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 20 (1-2) , 160-170
Abstract
Autologous mesenchymal stromal cell (MSC)-based therapies offer one of the most promising and safe methods for regeneration or reconstruction of tissues and organs. Routine procedures to obtain adequate amount of autologous stem cells need their expansion through culture, with risks of contamination and cell differentiation, leading to the loss of cell ability for therapies. We suggest the use of human bone marrow (BM) as a physiological bioreactor to produce autologous MSC by injection of autologous platelet-rich plasma activated by recombinant human soluble tissue factor (rhsTF) in iliac crest. A trial on 13 healthy volunteers showed the feasibility and harmlessness of the procedure. The phenotype and cellularity of BM cells were not modified, on day 3 after injection. Endothelial progenitor cells (EPC) were mobilized to the bloodstream, without stimulation of hematopoietic stem cells (HSC). MSC level in BM increased with a specific commitment to preosteoblastic cell population both in vivo and in vitro. This self-stimulation system of BM seems thus to be a promising feasible process 3 days before clinical cell therapy applications.Keywords
This publication has 41 references indexed in Scilit:
- Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active componentsCytotherapy, 2012
- Current Applications of Human Pluripotent Stem Cells: Possibilities and ChallengesCell Transplantation, 2012
- Population dynamics of mesenchymal stromal cells during culture expansionCytotherapy, 2012
- Tissue Engineering and Regenerative Medicine: History, Progress, and ChallengesAnnual Review of Chemical and Biomolecular Engineering, 2011
- Assessing the Value of Autologous and Allogeneic Cells for Regenerative MedicineRegenerative Medicine, 2009
- Heterogeneity of mesenchymal stromal cell preparationsCytotherapy, 2008
- From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?The International Journal of Developmental Biology, 2008
- Adult mesenchymal stem cells for tissue engineering versus regenerative medicineJournal of Cellular Physiology, 2007
- Study of Telomere Length Reveals Rapid Aging of Human Marrow Stromal Cells following In Vitro ExpansionStem Cells, 2004
- Mesenchymal stem cellsExperimental Hematology, 2000